Evidence map›Paper›PMID 35142234›Full record

SynthesisJournal of primary care & community health

Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Systematic Review.

Vikash Jaiswal, Gaurav Nepal, Patricia Dijamco, Angela Ishak, Mehak Dagar, Zouina Sarfraz, Nishat Shama, Azza Sarfraz, Kriti Lnu, Saloni Mitra and 4 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Observational
  10. Neuro-Ophthalmic Complications of COVID-19 Infection and Vaccination.Advances in ophthalmology and optometry · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 14 institutions in 8 countries.

Vikash JaiswalAMA School of Medicine, Makati, Philippines.ORCID 0000-0002-2021-1660
Gaurav NepalTribhuvan University Institute of Medicine, Kathmandu, Nepal.ORCID 0000-0001-5054-2711
Patricia DijamcoSt. Luke's Medical Center College of Medicine, Quezon City, Philippines.ORCID 0000-0001-5725-2880
Angela IshakEuropean University Cyprus School of Medicine, Nicosia, Cyprus.
Mehak DagarHimalayan Institute of Medical Science, Dehradun, Uttarakhand, India.
Zouina SarfrazFatima Jinnah Medical University, Lahore, Punjab, Pakistan.ORCID 0000-0002-5132-7455
Nishat ShamaBangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, Dhaka, Bangladesh.ORCID 0000-0001-9859-7949
Azza SarfrazThe Aga Khan University, Karachi, Pakistan.ORCID 0000-0001-8206-5745
Kriti LnuUPMC Harrisburg, Harrisburg, PA, USA.
Saloni MitraBogomolets National Medical University, Kyiv, Ukraine.
Preeti AgarwalaRajshahi Medical College and Hospital, Rajshahi, Bangladesh.
Sidra NazHarvard Medical School, Boston, MA, USA.ORCID 0000-0001-6390-9658
David SongIcahn School of Medicine at Mount Sinai, NY, USA.
Akash JaiswalAll India Institute of Medical Science, New Delhi, India.ORCID 0000-0002-5980-2361
Aga Khan University · PKAll India Institute of Medical Sciences · INAMA Computer University · PHBangladesh Institute of Research and Rehabilitation for Diabetes Endocrine and Metabolic Disorders · BDBogomolets National Medical University · UAEuropean University Cyprus · CYFatima Jinnah Medical University · PKHarvard University · USIcahn School of Medicine at Mount Sinai · USRajshahi Medical College · BDSt. Luke's Medical Center · PHSwami Rama Himalayan University · INTribhuvan University · NPUPMC Central Pa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOVID-19 vaccines became available after being carefully monitored in clinical trials with safety and efficacy on the human body. However, a few recipients developed unusual side effects, including cerebral venous sinus thrombosis (CVST). We aim to systematically review the baseline features, clinical characteristics, treatment, and outcomes in patients developing CVST post-COVID-19 vaccination.

methodsThis study was conducted according to the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) 2020 guideline. Investigators independently searched PubMed, Embase, and Google Scholar for English language articles published from inception up until September 10, 2021, reporting the incidence of CVST post-COVID-19 vaccines. We analyzed CVST patients' baseline data, type of vaccines, clinical findings, treatment, and outcomes. Our systematic review process yielded patient-level data.

resultThe final analysis included 25 studies that identified 80 patients who developed CVST after the COVID-19 vaccination. Of the 80 CVST cases, 31 (39.24%) patients died. There was no significant relationship between mortality and age (

conclusionCOVID-19 vaccine-associated CVST is associated with high mortality rate. Timely diagnosis and management can be lifesaving for patients.

Indexed as

COVID-19Sinus Thrombosis, IntracranialChAdOx1 nCoV-19COVID-19 VaccinesHumansSARS-CoV-2VaccinationChAdOx1 nCoV-19COVID-19 Vaccinescerebral venous sinus thrombosisCOVID-19COVID-19 vaccineCVSTvaccine

Identifiers

PMID35142234
PMCPMC8841914
OpenAlexW4211129369

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.